Comparing gene expression signatures of niraparib, olaparib treatment and PARP1 silencing in HRP ovarian cancer cells

International Journal of Gynecological Cancer 2026

View at publisher

Authors: Zhong Zheng

DOI: 10.1016/j.ijgc.2025.103894

Cited by: 0

Fields of Study & Subjects

PARP inhibition in cancer therapy BRCA gene mutations in cancer Ovarian cancer diagnosis and treatment